Seroprevalence of SARS-CoV-2 neutralising antibodies and cross-reactivity to JN.1 one year after the BA.5/BF.7 wave in China

Lancet Reg Health West Pac. 2024 Mar 8:44:101040. doi: 10.1016/j.lanwpc.2024.101040. eCollection 2024 Mar.
No abstract available